ReportsPhysical and psychologic measures are necessary to assess overall psoriasis severity☆,☆☆,★
Section snippets
Patients and methods
Patients with psoriasis were recruited from the dermatology inpatient ward, the specialist psoriasis clinic, and general dermatological clinics at the Dermatology Centre, Hope Hospital, Manchester, United Kingdom. All patients were 18 years of age or older and were not suffering from any severe mental health problems. The patients completed the SAPASI and several self-report psychologic questionnaires. The PASI was assessed in each patient by 1 of 3 clinicians (B. K., P. W., E. H.) experienced
Results
One hundred one patients with psoriasis (44 women, 57 men; mean age, 46 ± 1.7 years; range, 18-88 years) were assessed. This included 67 inpatients (30 women, 37 men; mean age, 46.4 ± 2.1 years; range, 18-88 years) and 34 outpatients (14 women, 20 men; mean age, 45.6 ± 3.1 years; range, 20-76 years). The overall mean PASI score was 14.7 ± 1.1.
Discussion
Psoriasis can cause significant physical and psychologic morbidity in those whom it affects.1, 6, 12 However, traditional measurements of psoriasis severity have concentrated on the physical aspects of the disease.2, 3, 13 Recently, indices have been developed that measure psoriasis-specific distress.4, 5 Although it is known that one of these, the PDI, correlates significantly but not completely with PASI,5 the psychometric properties of either PASI or PDI are unclear. Similarly, the SAPASI
Acknowledgements
We thank Dr A. B. Fleischer and Professor A. Y. Finlay for allowing us to use the Self-Administered PASI and Psoriasis Disability Index, respectively.
References (17)
- et al.
The outcomes movement and new measures of the severity of psoriasis
J Am Acad Dermatol
(1996) - et al.
Assessing illness-related stress in psoriasis: the psychometric properties of the psoriasis life stress inventory
J Psychosom Res
(1997) - et al.
The self-administered psoriasis area and severity index is valid and reliable
J Invest Dermatol
(1996) - et al.
What patients with psoriasis believe about their condition
J Am Acad Dermatol
(1998) - et al.
Psoriasis causes as much disability as other medical conditions
J Am Acad Dermatol
(1999) - et al.
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
J Am Acad Dermatol
(2000) - et al.
Severe psoriasis: oral therapy with a new retinoid
Dermatologica
(1978) - et al.
Assessment of disease progress in psoriasis
Arch Dermatol
(1989)
Cited by (161)
Exploring the therapeutic potential of functional excipient-based nanoemulgel of fluticasone propionate for the management of psoriasis
2023, Journal of Drug Delivery Science and TechnologyInfluence of psoriasis lesions' location and severity on psychosocial disability and psychopathology. Observational study and psychometric validation of the SAPASI Portuguese version
2022, Journal of Psychosomatic ResearchCitation Excerpt :BDI score was also found to correlate with the severity of psoriasis assessed with PASI [48]. Other studies have found no correlation between severity assessed with SAPASI and anxiety or depression [30]. However, in this particular case, a different instrument was used to assess psychopathology and only 101 patients were assessed, what could contribute to explain the differences observed.
Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment
2021, Current Research in Pharmacology and Drug DiscoveryPatient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study
2019, Journal of the American Academy of DermatologyIncreased risk of suicidality in patients with psoriasis: A Nationwide cohort study in Korea
2023, Journal of the European Academy of Dermatology and Venereology
- ☆
B. Kirby is supported in part by an unrestricted grant from Novartis Pharmaceuticals Limited.
- ☆☆
Reprints not available from authors.
- ★
J Am Acad Dermatol 2001;45:72-6.